华仁药业 (300110.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(华仁药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 42.0040.0047.0043.0042.0041.0043.0041.0049.00
 单季度销售净利率(%) 13.0013.0015.0010.0010.0011.0013.0015.007.00
 单季度净资产收益率ROE(%) 2.002.002.002.002.002.002.002.001.00
 单季度总资产净利率ROA(%) 1.001.001.001.001.001.001.001.00-
单季度财务摘要:
 单季度营业总收入(元) 406,703,156.00420,328,605.00386,881,442.00425,804,492.00403,241,818.00515,105,730.00382,428,802.00336,471,681.00385,486,123.00
 单季度营业总成本(元) 340,912,235.00372,518,793.00311,342,204.00371,234,743.00349,719,742.00444,903,906.00333,838,283.00273,269,796.00345,132,061.00
 单季度营业收入(元) 406,703,156.00420,328,605.00386,881,442.00425,804,492.00403,241,818.00515,105,730.00382,428,802.00336,471,681.00385,486,123.00
 单季度营业利润(元) 58,680,287.0071,195,251.0066,313,453.0041,756,061.0046,679,557.0053,606,023.0052,030,646.0059,746,415.0033,107,664.00
 单季度利润总额(元) 57,699,012.0073,300,581.0066,496,336.0043,965,998.0046,751,755.0054,290,588.0061,503,072.0057,630,373.0032,435,058.00
 单季度净利润(元) 52,378,184.0052,773,745.0056,212,808.0042,567,522.0041,870,661.0055,063,500.0050,241,062.0049,851,581.0026,181,500.00
 单季度归属母公司股东的净利润(元) 50,822,917.0050,979,443.0054,801,703.0041,178,982.0041,102,886.0057,604,774.0049,109,787.0049,061,639.0025,039,647.00
 单季度经营活动产生的现金流量(元) 110,516,833.00108,538,664.0071,408,227.0058,651,939.0066,998,644.00110,661,434.0071,201,456.0031,817,416.004,303,756.00
 单季度投资活动产生的现金流量(元) -12,045,611.00-11,883,083.00-9,818,109.00-4,385,158.00-71,050,197.00-12,677,085.0014,900,920.00-135,238,048.00-10,797,254.00
 单季度筹资活动产生的现金流量(元) -221,122,267.00-18,576,320.00-179,319,205.0068,410,215.008,761,039.00-64,739,003.00-122,881,822.0080,511,870.00-45,560,752.00
 单季度现金及现金等价物净增加(元) -122,652,566.0078,079,825.00-117,730,785.00122,677,114.004,709,094.0033,247,472.00-36,778,459.00-22,910,196.00-52,056,826.00

前瞻产业研究院